A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors

NCT04861987 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Refractory Cancer
Tumor Gastric

Interventions

DRUG: PCS6422 and capecitabine

Sponsor

Processa Pharmaceuticals